{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:01Z","timestamp":1762505701686,"version":"3.41.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/igc.0b013e3182060316","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T23:57:47Z","timestamp":1295999867000},"page":"424-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protocol Development for Ovarian Cancer Treatment in Kenya: A Brief Report"],"prefix":"10.1016","volume":"21","author":[{"given":"Lynn","family":"Sterling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"van Lonkhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job","family":"Nyangena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elkanah","family":"Orango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Strother","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafthali","family":"Busakhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182060316_bb0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182060316_bb0010","first-page":"115","article-title":"GICOG (Gruppo Interregionale Cooperativo Oncologico Ginecologia), Italy","volume":"45","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0015","first-page":"353","article-title":"Gruppo Interegionale Cooperativo Oncologico Ginecologia","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182060316_bb0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1200\/JCO.1986.4.6.965","article-title":"A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer","volume":"4","author":"Conte","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0020-7292(88)90008-2","article-title":"Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4-epi-doxorubicin in the treatment of advanced ovarian cancer","volume":"27","author":"Hernadi","year":"1988","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1097\/IGC.0b013e3182060316_bb0030","first-page":"77","article-title":"DACOVA. A multicenter study of ovarian cancer","volume":"147","author":"Bertelsen","year":"1985","journal-title":"Ugeskr Laeger"},{"key":"10.1097\/IGC.0b013e3182060316_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","article-title":"Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study","volume":"7","author":"Omura","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000238673","article-title":"A randomized study of high-dose versus low-dose cis-platinum combined with cyclophosphamide in the treatment of advanced ovarian cancer. Hong Kong Ovarian Carcinoma Study Group","volume":"35","author":"Ngan","year":"1989","journal-title":"Chemotherapy"},{"key":"10.1097\/IGC.0b013e3182060316_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0140-6736(92)91404-V","article-title":"Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer","volume":"340","author":"Kaye","year":"1992","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182060316_bb0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.1995.13.7.1589","article-title":"Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study","volume":"13","author":"McGuire","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0055","first-page":"1668","article-title":"The Ovarian Cancer Meta-analysis Project","volume":"9","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0959-8049(97)10171-X","article-title":"Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer","volume":"34","author":"Marth","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1097\/IGC.0b013e3182060316_bb0065","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/jnci\/85.21.1732","article-title":"Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis","volume":"85","author":"Levin","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/IGC.0b013e3182060316_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1097\/IGC.0b013e3182060316_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1992.10.5.706","article-title":"Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer","volume":"10","author":"Alberts","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1995.1273","article-title":"Meta-analysis comparing cisplatin total dose intensity and survival","volume":"59","author":"Ben-David","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182060316_bb0085","unstructured":"Global Health Observatory [database online] G, Switzerland: The World Health Organization. Updated 2007. Available at: http:\/\/apps.who.int\/ghodata\/. Accessed August 18, 2010."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24038155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24038155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e3182060316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:08:38Z","timestamp":1753232918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24038155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1048891X24038155"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182060316","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol Development for Ovarian Cancer Treatment in Kenya: A Brief Report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182060316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}